NSE BSE
genpharmasec limited stock

GENPHARMASEC LIMITED Share Price

- - (%)
- NSE: GENPHARMA

GENPHARMASEC LIMITED Share Price Update

As of the latest trading session, GENPHARMASEC LIMITED share price is currently at 2.3, which is down by -0.03 from its previous closing. Today, the stock has fluctuated between 2.28 and 2.38. Over the past year, GENPHARMASEC LIMITED has achieved a return of 16.41 %. In the last month alone, the return has been 16.99 %. Read More...

GENPHARMASEC LIMITED Performance

Day Range

Low2.28 High2.38
2.30

52 Week Range

Low 1.69 High 7.31
2.30

GENPHARMASEC LIMITED Share Price

531592

GENPHARMA

img img img img
No Data Available

Open Price

2.34

Prev. Close

2.34

Volume (Shares)

612555.00

Total traded value

14.08

Upper Circuit

.00

Lower Circuit

.00

Note: The current prices & values are delayed, Login to your account for live updates.

GENPHARMASEC LIMITED Fundamentals


(Standalone)

Market Cap (Cr) 127.35
PE Ratio (TTM) 0.00
Book Value / Share 1.16
Beta 0.61
ROE 0.11%
EPS (TTM) 0.00
Dividend Yield 0.00%
Net Profit Qtr (Cr) -0.05

GENPHARMASEC LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 10.20
Operating Expense 10.18
Net Profit -0.05
Net Profit Margin (%) -0.49
Earnings Per Share (EPS) 0.00
EBITDA 0.47
Effective Tax Rate (%) 115.15
Particulars DEC 2023 (Values in Cr)
Revenue 6.38
Operating Expense 6.49
Net Profit 0.06
Net Profit Margin (%) 0.94
Earnings Per Share (EPS) 0.00
EBITDA 0.15
Effective Tax Rate (%) -100.00
Particulars SEP 2023 (Values in Cr)
Revenue 7.86
Operating Expense 7.97
Net Profit 0.01
Net Profit Margin (%) 0.12
Earnings Per Share (EPS) 0.00
EBITDA 0.12
Effective Tax Rate (%) 80.00
Particulars JUN 2023 (Values in Cr)
Revenue 5.96
Operating Expense 6.01
Net Profit 0.03
Net Profit Margin (%) 0.50
Earnings Per Share (EPS) 0.00
EBITDA 0.13
Effective Tax Rate (%) 66.66
Particulars MAR 2023 (Values in Cr)
Revenue 6.22
Operating Expense 6.07
Net Profit 1.05
Net Profit Margin (%) 16.88
Earnings Per Share (EPS) 0.04
EBITDA 0.27
Effective Tax Rate (%) -419.99
Particulars MAR 2024 (Values in Cr)
Revenue 30.41
Operating Expense 30.65
Net Profit 0.05
Net Profit Margin (%) 0.16
Earnings Per Share (EPS) 0.00
EBITDA 0.88
Effective Tax Rate (%) 89.36
Particulars MAR 2023 (Values in Cr)
Revenue 25.52
Operating Expense 25.34
Net Profit 1.12
Net Profit Margin (%) 4.38
Earnings Per Share (EPS) 0.04
EBITDA 0.36
Effective Tax Rate (%) -299.99
Particulars MAR 2022 (Values in Cr)
Revenue 27.32
Operating Expense 27.86
Net Profit -0.21
Net Profit Margin (%) -0.76
Earnings Per Share (EPS) -0.01
EBITDA -0.43
Effective Tax Rate (%) 52.27
Particulars MAR 2021 (Values in Cr)
Revenue 21.31
Operating Expense 20.13
Net Profit 1.26
Net Profit Margin (%) 5.91
Earnings Per Share (EPS) 0.05
EBITDA 1.52
Effective Tax Rate (%) 16.55
Particulars MAR 2020 (Values in Cr)
Revenue 16.50
Operating Expense 15.86
Net Profit 1.01
Net Profit Margin (%) 6.12
Earnings Per Share (EPS) 0.05
EBITDA 1.21
Effective Tax Rate (%) 16.52
Particulars MAR 2024 (Values in Cr)
Book Value / Share 1.16
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.09
EBITDA Margin 2.30
Particulars MAR 2023 (Values in Cr)
Book Value / Share 0.55
ROE % 5.63
ROCE % 1.48
Total Debt to Total Equity 0.20
EBITDA Margin 1.41
Particulars MAR 2024 (Values in Cr)
Book Value / Share 1.17
ROE % 0.11
ROCE % 1.81
Total Debt to Total Equity 0.08
EBITDA Margin 2.86
Particulars MAR 2023 (Values in Cr)
Book Value / Share 0.55
ROE % 6.35
ROCE % 1.77
Total Debt to Total Equity 0.10
EBITDA Margin 1.41
Particulars MAR 2022 (Values in Cr)
Book Value / Share 0.56
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -1.57
Particulars MAR 2021 (Values in Cr)
Book Value / Share 0.75
ROE % 6.35
ROCE % 7.61
Total Debt to Total Equity 0.00
EBITDA Margin 7.13
Particulars MAR 2020 (Values in Cr)
Book Value / Share 0.81
ROE % 4.85
ROCE % 5.81
Total Debt to Total Equity 0.00
EBITDA Margin 7.33
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 18.83
Total Assets 71.12
Total Liabilities 71.12
Total Equity 64.53
Share Outstanding 553719700
Price to Book Ratio 1.91
Return on Assets (%) -0.17
Return on Capital (%) -0.19
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1.99
Total Assets 19.87
Total Liabilities 19.87
Total Equity 15.33
Share Outstanding 276859850
Price to Book Ratio 5.65
Return on Assets (%) 5.65
Return on Capital (%) 6.11
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 18.57
Total Assets 70.47
Total Liabilities 70.47
Total Equity 64.56
Share Outstanding 553719700
Price to Book Ratio 1.91
Return on Assets (%) 0.06
Return on Capital (%) 0.07
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1.99
Total Assets 19.87
Total Liabilities 19.87
Total Equity 15.33
Share Outstanding 276859850
Price to Book Ratio 5.65
Return on Assets (%) 5.65
Return on Capital (%) 6.11
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.60
Total Assets 21.65
Total Liabilities 21.65
Total Equity 15.36
Share Outstanding 276859850
Price to Book Ratio 9.82
Return on Assets (%) -0.96
Return on Capital (%) -1.36
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 3.53
Total Assets 27.81
Total Liabilities 27.81
Total Equity 20.66
Share Outstanding 276859850
Price to Book Ratio 10.68
Return on Assets (%) 4.51
Return on Capital (%) 6.09
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 2.57
Total Assets 24.75
Total Liabilities 24.75
Total Equity 19.03
Share Outstanding 216859850
Price to Book Ratio 15.99
Return on Assets (%) 4.07
Return on Capital (%) 5.3
Particulars MAR 2024 (Values in Cr)
Net Income 0.25
Cash from Operations -2.90
Cash from Investing -28.06
Cash from Financing 47.84
Net change in Cash 16.83
Free Cash Flow -2.88
Particulars MAR 2023 (Values in Cr)
Net Income 0.28
Cash from Operations -3.32
Cash from Investing 0.36
Cash from Financing 3.08
Net change in Cash 0.38
Free Cash Flow -3.30
Particulars MAR 2024 (Values in Cr)
Net Income 0.46
Cash from Operations -2.23
Cash from Investing -29.03
Cash from Financing 47.89
Net change in Cash 16.58
Free Cash Flow -2.21
Particulars MAR 2023 (Values in Cr)
Net Income 0.28
Cash from Operations -3.32
Cash from Investing 0.36
Cash from Financing 3.08
Net change in Cash 0.38
Free Cash Flow -3.30
Particulars MAR 2022 (Values in Cr)
Net Income -0.44
Cash from Operations -2.31
Cash from Investing 0.41
Cash from Financing 0.00
Net change in Cash -1.92
Free Cash Flow -2.23
Particulars MAR 2021 (Values in Cr)
Net Income 1.50
Cash from Operations -1.78
Cash from Investing -1.41
Cash from Financing 4.50
Net change in Cash 0.95
Free Cash Flow -1.77
Particulars MAR 2020 (Values in Cr)
Net Income 1.20
Cash from Operations 1.44
Cash from Investing -4.01
Cash from Financing 0.00
Net change in Cash -2.62
Free Cash Flow 1.49
Company Name Price P/E P/B Market Cap 52 Week Low/High
GENPHARMASEC LIMITED 2.34 0.00 2.01 129.57 1.69 / 7.31
AEGIS LOGISTICS LIMITED 897.00 56.17 8.08 31484.70 280.00 / 969.95
AMBALAL SARABHAI ENTERPRISES L 70.87 95.77 3.96 543.10 26.05 / 77.70
KOTHARI INDUSTRIAL CORPORATION 10.22 0.62 -1.85 19.53 1.80 / 10.22
MYSORE PETRO CHEMICALS LTD. 173.40 15.28 0.51 114.16 121.10 / 235.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
GENPHARMASEC LIMITED 2.34 0.00 2.00 129.57 1.69 / 7.31
AEGIS LOGISTICS LIMITED 897.00 77.60 13.21 31484.70 280.00 / 969.95
AMBALAL SARABHAI ENTERPRISES L 70.87 208.44 13.47 543.10 26.05 / 77.70
COMPUTER POINT LTD. 10.33 0.00 0.92 30.99 2.26 / 11.63
NOVARTIS INDIA LTD. 1171.90 34.77 3.88 2893.51 599.95 / 1224.00

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 2.30
  • 26 Days 2.20
  • 10 Days 2.30
  • 50 Days 2.20
  • 12 Days 2.30
  • 100 Days 2.50
  • 20 Days 2.20
  • 200 Days 2.50
2.32
PIVOT
First Resistance 2.36
Second Resistance 2.39
Third Resistance 2.43
First Support 2.29
Second Support 2.25
Third Support 2.22
RSI 72.16
MACD 0.10
Commodity Channel Index (CCI) 57.99
ADX 47.06
Williams % R -30.43

Over 1 Month

down

16.99

Over 3 Months

down

-1.26

Over 6 Months

down

-64.70

Over 1 Year

down

16.41

Over 3 Years

down

-25.28

Over 5 Years

down

-23.42

GENPHARMASEC LIMITED Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

GENPHARMASEC LIMITED Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
70.01
Promoter Holdings
29.97
FII
0.0
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Sneha Sadhwani Shareholding of Promoter and Promoter Group 9.3001E7 16.8
Rajesh Sadhwani Shareholding of Promoter and Promoter Group 7.3E7 13.18
Yogeshkumar Rasiklal Sanghavi Public Shareholding 4.33E7 7.82
Divya Deven Pathak Public Shareholding 1.10086E7 1.99
Sadashiv Kanyana Shetty Public Shareholding 9942002.0 1.8
Vishesh Mahesh Nihalani Public Shareholding 8400501.0 1.52
Rashmi Nimesh Joshi Public Shareholding 7089510.0 1.28
Narendra Chhaganlal Solanki Public Shareholding 6009409.0 1.09
Ramesh Sakharampant Deshpande Public Shareholding 6000000.0 1.08

GENPHARMASEC LIMITED

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date
2019-04-11 10.0 1.0 2019-04-12

Learn More About Stocks

About GENPHARMASEC LIMITED

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by GENPHARMASEC LIMITED

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Genpharmasec Ltd?

Answer Field

The share price of Genpharmasec Ltd for NSE is ₹ 0.00 and for BSE is ₹ 2.29.

What is the Market Cap of Genpharmasec Ltd?

Answer Field

The market cap of Genpharmasec Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 126.80 Cr. as of now.

What is the 52 Week High and Low of Genpharmasec Ltd?

Answer Field

The 52 Week High and Low of Genpharmasec Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 7.31 and ₹ 1.69.

How to Buy Genpharmasec Ltd share?

Answer Field

You can trade in Genpharmasec Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Genpharmasec Ltd?

Answer Field

The 1 year returns on the stock has been 16.41%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7.5 Lacs+ Users

icon-with-text

4.3+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4300 Cr MTF Book

icon-with-text
loader